Last 12 months
Inside the activity.
2 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2020 Filed Feb 13, 2020 02:33 UTC |
McCreedy Bruce J Jr.Director
|
PurchaseCommon Stock | 8,700 | $1.15 | $10,005.00 |
DisclosureSEC source: 0000899243-20-004417 · doc4.xml · nonDerivative · entry 1 McCreedy Bruce J Jr. · CIK 0001769750 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,700 Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 02:32 UTC |
Arthur David J.Director · Chief Executive Officer
|
PurchaseCommon Stock | 2,175 | $1.15 | $2,501.25 |
DisclosureSEC source: 0000899243-20-004413 · doc4.xml · nonDerivative · entry 1 Arthur David J. · CIK 0001769331 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,546 Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 02:02 UTC |
HANISH ARNOLD CDirector
|
PurchaseWarrants (right to buy) · Derivative | 4,350 | $0.01 Strike: $1.15 | $43.50 |
DisclosureSEC source: 0000899243-20-004560 · doc4.xml · derivative · entry 1 HANISH ARNOLD C · CIK 0001233253 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,350 Underlying: Common Stock · 4,350 shares Expires 2025-02-11 F1 · security: The Reporting Person acquired these securities in the Issuer's public offering of Class A Units on February 11, 2020. Each Class A Unit consisted of one share of Common Stock and one warrant to purchase a single share of Common Stock. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 02:07 UTC |
Arthur David J.Director · Chief Executive Officer
|
PurchaseWarrants (right to buy) · Derivative | 2,175 | $0.01 Strike: $1.15 | $21.75 |
DisclosureSEC source: 0000899243-20-004567 · doc4.xml · derivative · entry 1 Arthur David J. · CIK 0001769331 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,175 Underlying: Common Stock · 2,175 shares Expires 2025-02-11 F1 · security: The Reporting Person acquired these securities in the Issuer's public offering of Class A Units on February 11, 2020. Each Class A Unit consisted of one share of Common Stock and one warrant to purchase a single share of Common Stock. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 02:06 UTC |
Northrup Jonathan PDirector
|
PurchaseWarrants (right to buy) · Derivative | 8,700 | $0.01 Strike: $1.15 | $87.00 |
DisclosureSEC source: 0000899243-20-004566 · doc4.xml · derivative · entry 1 Northrup Jonathan P · CIK 0001770559 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,700 Underlying: Common Stock · 8,700 shares Expires 2025-02-11 F1 · security: The Reporting Person acquired these securities in the Issuer's public offering of Class A Units on February 11, 2020. Each Class A Unit consisted of one share of Common Stock and one warrant to purchase a single share of Common Stock. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 02:05 UTC |
Burleson TessDirector
|
PurchaseWarrants (right to buy) · Derivative | 4,350 | $0.01 Strike: $1.15 | $43.50 |
DisclosureSEC source: 0000899243-20-004563 · doc4.xml · derivative · entry 1 Burleson Tess · CIK 0001769749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,350 Underlying: Common Stock · 4,350 shares Expires 2025-02-11 F1 · security: The Reporting Person acquired these securities in the Issuer's public offering of Class A Units on February 11, 2020. Each Class A Unit consisted of one share of Common Stock and one warrant to purchase a single share of Common Stock. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 02:02 UTC |
McVicar William K.Director
|
PurchaseWarrants (right to buy) · Derivative | 8,700 | $0.01 Strike: $1.15 | $87.00 |
DisclosureSEC source: 0000899243-20-004561 · doc4.xml · derivative · entry 1 McVicar William K. · CIK 0001634368 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,700 Underlying: Common Stock · 8,700 shares Expires 2025-02-11 F1 · security: The Reporting Person acquired these securities in the Issuer's public offering of Class A Units on February 11, 2020. Each Class A Unit consisted of one share of Common Stock and one warrant to purchase a single share of Common Stock. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 02:00 UTC |
McCreedy Bruce J Jr.Director
|
PurchaseWarrants (right to buy) · Derivative | 8,700 | $0.01 Strike: $1.15 | $87.00 |
DisclosureSEC source: 0000899243-20-004558 · doc4.xml · derivative · entry 1 McCreedy Bruce J Jr. · CIK 0001769750 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,700 Underlying: Common Stock · 8,700 shares Expires 2025-02-11 F1 · security: The Reporting Person acquired these securities in the Issuer's public offering of Class A Units on February 11, 2020. Each Class A Unit consisted of one share of Common Stock and one warrant to purchase a single share of Common Stock. Read SEC document |
| February 11, 2020 Filed Jun 7, 2022 00:28 UTC Amendment |
HANISH ARNOLD CDirector
|
PurchaseCommon Stock | 4,350 | $1.15 | $5,002.50 |
DisclosureSEC source: 0001615219-22-000091 · wf-form4a_165456170682482.xml · nonDerivative · entry 1 HANISH ARNOLD C · CIK 0001233253 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Arnold C. Hanish Trust Disclosed balance after: 7,350 F1 · security: This Form 4/A is being filed to amend the Form 4 filed by the Reporting Person on February 12, 2020 to reflect that the securities reported are indirectly beneficially owned as indicated herein. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 13:47 UTC |
HANISH ARNOLD CDirector
|
PurchaseCommon Stock | 3,000 | $3.59 | $10,770.00 |
DisclosureSEC source: 0001615219-19-000055 · wf-form4_157477604835031.xml · nonDerivative · entry 1 HANISH ARNOLD C · CIK 0001233253 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Read SEC document |
| November 25, 2019 Filed Feb 13, 2020 02:27 UTC Amendment |
HANISH ARNOLD CDirector
|
PurchaseCommon Stock | 3,000 | $3.59 | $10,770.00 |
DisclosureSEC source: 0000899243-20-004410 · doc4a.xml · nonDerivative · entry 1 HANISH ARNOLD C · CIK 0001233253 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 F1 · security: This Form 4/A is being filed to amend the Form 4 filed by the Reporting Person on November 26, 2019 to correct the amount of securities beneficially owned following the reported transaction under Box 5 of Table I as reflected herein. Read SEC document |
| November 25, 2019 Filed Jun 7, 2022 00:27 UTC Amendment |
HANISH ARNOLD CDirector
|
PurchaseCommon Stock | 3,000 | $3.59 | $10,770.00 |
DisclosureSEC source: 0001615219-22-000089 · wf-form4a_165456160903374.xml · nonDerivative · entry 1 HANISH ARNOLD C · CIK 0001233253 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Arnold C. Hanish Trust Disclosed balance after: 3,000 F1 · security: This Form 4/A is being filed to amend the Form 4 filed by the Reporting Person on November 26, 2019 to reflect that the securities reported are indirectly beneficially owned as indicated herein. Read SEC document |
| September 10, 2019 Filed Sep 12, 2019 21:59 UTC |
Lammers PaulDirector
|
GrantStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $8.00 | $0.00 |
DisclosureSEC source: 0001615219-19-000034 · wf-form4_156833993937396.xml · derivative · entry 1 Lammers Paul · CIK 0001457289 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2029-09-10 Read SEC document |
| September 10, 2019 Filed Sep 13, 2019 01:57 UTC |
HANISH ARNOLD CDirector
|
GrantStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $8.00 | $0.00 |
DisclosureSEC source: 0001615219-19-000030 · wf-form4_156833986050609.xml · derivative · entry 1 HANISH ARNOLD C · CIK 0001233253 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2029-09-10 Read SEC document |
| September 10, 2019 Filed Sep 13, 2019 01:58 UTC |
McCreedy Bruce J Jr.Director
|
GrantStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $8.00 | $0.00 |
DisclosureSEC source: 0001615219-19-000032 · wf-form4_156833989937456.xml · derivative · entry 1 McCreedy Bruce J Jr. · CIK 0001769750 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2029-09-10 Read SEC document |
| September 10, 2019 Filed Sep 13, 2019 01:59 UTC |
Jordan ScottChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $8.00 | $0.00 |
DisclosureSEC source: 0001615219-19-000035 · wf-form4_156833996436654.xml · derivative · entry 1 Jordan Scott · CIK 0001769747 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-09-10 F1 · derivative.exercise_date: The grant has a 4-year vesting schedule with 25% vesting on September 30, 2020 and 1/12th of the balance vesting on the last day of each calendar quarter thereafter. Read SEC document |
| September 10, 2019 Filed Sep 13, 2019 01:58 UTC |
Chuang Pao-YuController
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $8.00 | $0.00 |
DisclosureSEC source: 0001615219-19-000033 · wf-form4_156833991916830.xml · derivative · entry 1 Chuang Pao-Yu · CIK 0001782864 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-09-10 F1 · derivative.exercise_date: The grant has a 4-year vesting schedule with 25% vesting on September 30, 2020 and 1/12th of the balance vesting on the last day of each calendar quarter thereafter. Read SEC document |
| September 10, 2019 Filed Sep 13, 2019 01:58 UTC |
McVicar William K.Director
|
GrantStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $8.00 | $0.00 |
DisclosureSEC source: 0001615219-19-000031 · wf-form4_156833987897245.xml · derivative · entry 1 McVicar William K. · CIK 0001634368 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2029-09-10 F1 · security: On July 19, 2019, the Issuer effected a 1-for-25 reverse stock split of its then outstanding common stock, resulting in the reporting person's ownership of 34,385 options. Read SEC document |
| September 10, 2019 Filed Sep 13, 2019 22:31 UTC Amendment |
Jordan ScottChief Business Officer
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $8.00 | $0.00 |
DisclosureSEC source: 0001615219-19-000041 · wf-form4a_156841388132729.xml · derivative · entry 1 Jordan Scott · CIK 0001769747 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-09-10 F1 · derivative.exercise_date: The grant has a 4-year vesting schedule with 25% vesting on September 30, 2020 and 1/12th of the balance vesting on the last day of each calendar quarter thereafter. Read SEC document |
| September 10, 2019 Filed Sep 13, 2019 10:16 UTC |
Arthur David J.Director · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $8.00 | $0.00 |
DisclosureSEC source: 0001615219-19-000039 · wf-form4_156836979901866.xml · derivative · entry 1 Arthur David J. · CIK 0001769331 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2029-09-10 F1 · derivative.exercise_date: The grant has a 4-year vesting schedule with 25% vesting on September 30, 2020 and 1/12th of the balance vesting on the last day of each calendar quarter thereafter. Read SEC document |
| September 10, 2019 Filed Sep 13, 2019 10:16 UTC |
Burleson TessDirector
|
GrantStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $8.00 | $0.00 |
DisclosureSEC source: 0001615219-19-000038 · wf-form4_156836977739908.xml · derivative · entry 1 Burleson Tess · CIK 0001769749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2029-09-10 Read SEC document |
| September 10, 2019 Filed Sep 13, 2019 10:16 UTC |
Northrup Jonathan PDirector
|
GrantStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $8.00 | $0.00 |
DisclosureSEC source: 0001615219-19-000037 · wf-form4_156836975523831.xml · derivative · entry 1 Northrup Jonathan P · CIK 0001770559 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2029-09-10 Read SEC document |
| January 30, 2019 Filed Feb 5, 2019 15:03 UTC |
Boston Foundation, Inc.10% owner
|
SaleCommon Stock, par value $0.0001 | 1,600,000 | $0.33 | $521,600.00 |
DisclosureSEC source: 0001762003-19-000004 · primary_doc.xml · nonDerivative · entry 1 Boston Foundation, Inc. · CIK 0001762003 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,200,000 Read SEC document |
| January 09, 2019 Filed Jan 10, 2019 14:48 UTC |
Boston Foundation, Inc.10% owner
|
SaleCommon Stock, par value $0.0001 | 337,000 | $0.37 | $123,847.50 |
DisclosureSEC source: 0001762003-19-000002 · primary_doc.xml · nonDerivative · entry 1 Boston Foundation, Inc. · CIK 0001762003 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600,000 Read SEC document |
| January 08, 2019 Filed Jan 9, 2019 16:26 UTC |
Boston Foundation, Inc.10% owner
|
SaleCommon Stock, par value $0.0001 | 263,000 | $0.40 | $104,305.80 |
DisclosureSEC source: 0001762003-19-000001 · primary_doc.xml · nonDerivative · entry 1 Boston Foundation, Inc. · CIK 0001762003 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,937,000 Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 17:03 UTC |
Westphal Christoph H10% owner
|
GiftCommon Stock | 2,200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-074495 · a5.xml · nonDerivative · entry 2 Westphal Christoph H · CIK 0001291961 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 844,627 Read SEC document |
| November 06, 2018 Filed Dec 21, 2018 17:03 UTC |
Westphal Christoph H10% owner
|
GiftCommon Stock | 858,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-074495 · a5.xml · nonDerivative · entry 1 Westphal Christoph H · CIK 0001291961 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,044,627 Read SEC document |
| October 16, 2018 Filed Oct 18, 2018 17:02 UTC |
Westphal Christoph H10% owner
|
SaleCommon Stock | 3,212,861 | $0.92 | $2,941,052.96 |
DisclosureSEC source: 0001104659-18-062807 · a4.xml · nonDerivative · entry 2 Westphal Christoph H · CIK 0001291961 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.70 to $1.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. F2 · ownership.nature: No shares were sold by Christoph Westphal, M.D., Ph.D. ("Westphal") in this transaction. Represents 2,697,264 shares sold by Longwood Fund II, L.P. ("Longwood Fund II") and 515,597 shares sold by Longwood Fund III, L.P. ("Longwood Fund III"). Longwood Fund II GP, LLC is the General Partner of Longwood Fund II and Longwood Fund III GP, LLC is the General Partner of Longwood Fund III. The managers of Longwood Fund II GP, LLC and Longwood Fund III GP, LLC (the "Managers") have delegated their voting and dispositive power with respect to the Issuer's securities held by Longwood Fund II and Longwood Fund III (the "Longwood Shares") to a committee comprised of three members, one of which is Westphal (the "Longwood Committee"). F3 · ownership.nature: The Longwood Committee approves investment and voting decisions by a majority vote, and no individual member has sole control or voting power over the Longwood Shares. Each of Westphal, Longwood Fund II GP, LLC, Longwood Fund III GP, LLC, the Managers and the members of the Longwood Committee disclaim beneficial ownership of the Longwood Shares, except to the extent of their respective pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the shares for purposes of Section 16 or for any other purpose. Read SEC document |
| October 16, 2018 Filed Oct 18, 2018 17:03 UTC |
Longwood Fund II, L.P.10% owner
|
SaleCommon Stock | 3,212,861 | $0.92 | $2,941,052.96 |
DisclosureSEC source: 0001104659-18-062810 · a4.xml · nonDerivative · entry 1 Longwood Fund II, L.P. · CIK 0001543245 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.70 to $1.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. F2 · ownership.direct: Represents 2,697,264 shares sold by Longwood Fund II, L.P. ("Longwood Fund II") and 515,597 shares sold by Longwood Fund III, L.P. ("Longwood Fund III"). F3 · ownership.direct: Longwood Fund II GP, LLC is the General Partner of Longwood Fund II and Longwood Fund III GP, LLC is the General Partner of Longwood Fund III. Christoph Westphal, M.D., Ph.D. and Richard Aldrich (collectively, the "Managers") are managers of Longwood Fund II GP, LLC and Longwood Fund III GP, LLC. The Managers have delegated their voting and dispositive power with respect to the Issuer's securities held by Longwood Fund II and Longwood Fund III (the "Longwood Shares") to a committee comprised of three members, two of which such members include the Managers (the "Longwood Committee"). F4 · ownership.direct: The Longwood Committee approves investment and voting decisions by a majority vote, and no individual member has sole control or voting power over the Longwood Shares. Each of Longwood Fund II GP, LLC, Longwood Fund III GP, LLC, the Managers and the members of the Longwood Committee disclaim beneficial ownership of the Longwood Shares, except to the extent of their respective pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the shares for purposes of Section 16 or for any other purpose. Read SEC document |
| July 25, 2018 Filed Jul 26, 2018 15:52 UTC |
HUTT PETER BARTONDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.82 | $0.00 |
DisclosureSEC source: 0001615219-18-000043 · wf-form4_153263472568123.xml · derivative · entry 1 HUTT PETER BARTON · CIK 0001171527 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-07-25 F1 · derivative.exercise_date: The stock option will vest in 12 successive equal monthly installments measured from June 6, 2018. Read SEC document |
| July 25, 2018 Filed Jul 26, 2018 16:01 UTC |
Stacy MichelleDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.82 | $0.00 |
DisclosureSEC source: 0001615219-18-000045 · wf-form4_153263525068099.xml · derivative · entry 1 Stacy Michelle · CIK 0001448355 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-07-25 F1 · derivative.exercise_date: The stock option will vest in 12 successive equal monthly installments measured from June 6, 2018. Read SEC document |
| July 25, 2018 Filed Jul 26, 2018 20:04 UTC |
KOZIN MARC DDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.82 | $0.00 |
DisclosureSEC source: 0001615219-18-000046 · wf-form4_153263542891597.xml · derivative · entry 1 KOZIN MARC D · CIK 0001241647 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-07-25 F1 · derivative.exercise_date: The stock option will vest in 12 successive equal monthly installments measured from June 6, 2018. Read SEC document |
| July 25, 2018 Filed Jul 26, 2018 20:07 UTC |
RANDLE STUART ADirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.82 | $0.00 |
DisclosureSEC source: 0001615219-18-000047 · wf-form4_153263561757068.xml · derivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-07-25 F1 · derivative.exercise_date: The stock option will vest in 12 successive equal monthly installments measured from June 6, 2018. Read SEC document |
| July 25, 2018 Filed Jul 26, 2018 15:57 UTC |
Tung Roger DDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.82 | $0.00 |
DisclosureSEC source: 0001615219-18-000044 · wf-form4_153263500692824.xml · derivative · entry 1 Tung Roger D · CIK 0001594857 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-07-25 F1 · derivative.exercise_date: The stock option will vest in 12 successive equal monthly installments measured from June 6, 2018. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 20:14 UTC |
McCabe John P.Chief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 179,848 | $0.00 Strike: $1.35 | $0.00 |
DisclosureSEC source: 0001615219-18-000038 · wf-form4_152935285457366.xml · derivative · entry 1 McCabe John P. · CIK 0001630720 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,848 Underlying: Common Stock · 179,848 shares Expires 2028-06-14 F1 · derivative.exercise_date: The stock option will vest in 48 successive equal monthly installments measured from June 14, 2018. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 20:08 UTC |
McVicar William K.Director · President and CEO
|
GrantStock Option (right to buy) · Derivative | 359,696 | $0.00 Strike: $1.35 | $0.00 |
DisclosureSEC source: 0001615219-18-000037 · wf-form4_152935250734695.xml · derivative · entry 1 McVicar William K. · CIK 0001634368 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,696 Underlying: Common Stock · 359,696 shares Expires 2028-06-14 F1 · derivative.exercise_date: The stock option will vest in 48 successive equal monthly installments measured from June 14, 2018. Read SEC document |
| January 17, 2018 Filed Jan 19, 2018 09:43 UTC |
Wessel ThomasChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $3.98 | $0.00 |
DisclosureSEC source: 0001615219-18-000004 · wf-form4_151637301079957.xml · derivative · entry 1 Wessel Thomas · CIK 0001456055 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-01-17 F1 · derivative.exercise_date: The stock option will vest in 48 successive equal monthly installments measured from January 17, 2018. Read SEC document |
| January 17, 2018 Filed Jan 19, 2018 15:24 UTC |
McVicar William K.Director · President and CEO
|
GrantStock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $3.98 | $0.00 |
DisclosureSEC source: 0001615219-18-000007 · wf-form4_151637546439092.xml · derivative · entry 1 McVicar William K. · CIK 0001634368 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2028-01-17 F1 · derivative.exercise_date: The stock option will vest in 48 successive equal monthly installments measured from January 17, 2018. Read SEC document |
| January 17, 2018 Filed Jan 19, 2018 15:15 UTC |
Woo ElizabethSVP, Investor Relations
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $3.98 | $0.00 |
DisclosureSEC source: 0001615219-18-000006 · wf-form4_151637490293134.xml · derivative · entry 1 Woo Elizabeth · CIK 0001630686 · SVP, Investor Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2028-01-17 F1 · derivative.exercise_date: The stock option will vest in 48 successive equal monthly installments measured from January 17, 2018. Read SEC document |
| January 17, 2018 Filed Jan 19, 2018 15:00 UTC |
McCabe John P.Chief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $3.98 | $0.00 |
DisclosureSEC source: 0001615219-18-000005 · wf-form4_151637400432045.xml · derivative · entry 1 McCabe John P. · CIK 0001630720 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-01-17 F1 · derivative.exercise_date: The stock option will vest in 48 successive equal monthly installments measured from January 17, 2018. Read SEC document |
| November 08, 2017 Filed Nov 13, 2017 08:02 UTC |
Tung Roger DDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $3.47 | $0.00 |
DisclosureSEC source: 0001615219-17-000084 · wf-form4_151057810891449.xml · derivative · entry 1 Tung Roger D · CIK 0001594857 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-11-08 F1 · derivative.exercise_date: The stock option will vest in 36 successive equal monthly installments measured from November 8, 2017. Read SEC document |
| July 26, 2017 Filed Jul 27, 2017 08:50 UTC |
HUTT PETER BARTONDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $4.08 | $0.00 |
DisclosureSEC source: 0001615219-17-000050 · wf-form4_150115980932435.xml · derivative · entry 1 HUTT PETER BARTON · CIK 0001171527 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-07-26 F1 · derivative.exercise_date: The stock option will vest in 12 successive equal monthly installments measured from July 26, 2017. Read SEC document |
| July 26, 2017 Filed Jul 27, 2017 08:54 UTC |
Stacy MichelleDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $4.08 | $0.00 |
DisclosureSEC source: 0001615219-17-000055 · wf-form4_150116003024208.xml · derivative · entry 1 Stacy Michelle · CIK 0001448355 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-07-26 F1 · derivative.exercise_date: The stock option will vest in 12 successive equal monthly installments measured from July 26, 2017. Read SEC document |
| July 26, 2017 Filed Jul 27, 2017 08:54 UTC |
Westphal Christoph HDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $4.08 | $0.00 |
DisclosureSEC source: 0001615219-17-000056 · wf-form4_150116007433619.xml · derivative · entry 1 Westphal Christoph H · CIK 0001291961 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-07-26 F1 · derivative.exercise_date: The stock option will vest in 12 successive equal monthly installments measured from July 26, 2017. Read SEC document |
| July 26, 2017 Filed Jul 27, 2017 12:57 UTC |
PEREZ ROBERT JDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $4.08 | $0.00 |
DisclosureSEC source: 0001615219-17-000059 · wf-form4_150116026485727.xml · derivative · entry 1 PEREZ ROBERT J · CIK 0001263230 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-07-26 F1 · derivative.exercise_date: The stock option will vest in 12 successive equal monthly installments measured from July 26, 2017. Read SEC document |
| July 26, 2017 Filed Jul 27, 2017 12:51 UTC |
KOZIN MARC DDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $4.08 | $0.00 |
DisclosureSEC source: 0001615219-17-000051 · wf-form4_150115985633013.xml · derivative · entry 1 KOZIN MARC D · CIK 0001241647 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-07-26 F1 · derivative.exercise_date: The stock option will vest in 12 successive equal monthly installments measured from July 26, 2017. Read SEC document |
| July 26, 2017 Filed Jul 27, 2017 12:49 UTC |
CAPELLO JEFFREY DDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $4.08 | $0.00 |
DisclosureSEC source: 0001615219-17-000049 · wf-form4_150115975112524.xml · derivative · entry 1 CAPELLO JEFFREY D · CIK 0001224108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-07-26 F1 · derivative.exercise_date: The stock option will vest in 12 successive equal monthly installments measured from July 26, 2017. Read SEC document |
| July 26, 2017 Filed Jul 27, 2017 12:53 UTC |
RANDLE STUART ADirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $4.08 | $0.00 |
DisclosureSEC source: 0001615219-17-000054 · wf-form4_150115998197680.xml · derivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-07-26 F1 · derivative.exercise_date: The stock option will vest in 12 successive equal monthly installments measured from July 26, 2017. Read SEC document |
| July 26, 2017 Filed Jul 27, 2017 12:52 UTC |
McVicar William K.President and CEO
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $4.08 | $0.00 |
DisclosureSEC source: 0001615219-17-000053 · wf-form4_150115993838604.xml · derivative · entry 1 McVicar William K. · CIK 0001634368 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-07-26 F1 · derivative.exercise_date: The stock option will vest in 48 successive equal monthly installments measured from July 3, 2017. Read SEC document |
| July 26, 2017 Filed Jul 27, 2017 12:51 UTC |
MacKinnon RoderickDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $4.08 | $0.00 |
DisclosureSEC source: 0001615219-17-000052 · wf-form4_150115989964405.xml · derivative · entry 1 MacKinnon Roderick · CIK 0001634768 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-07-26 F1 · derivative.exercise_date: The stock option will vest in 12 successive equal monthly installments measured from July 26, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.